INSUBCONTINENT EXCLUSIVE:
With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based
startup Gallant is now opening its doors for the first time.The company was founded by DogVacay founder and chief executive Aaron Hirschhorn
I knew there had to be a better way to treat and heal our pets, which sparked the beginning of Gallant
Linda Black, an experienced serial entrepreneur at life sciences companies like Medicus Biosciences and SciStem, which both focused on
developing regenerative therapies
Richard Jennings, the chief executive of cord blood banking company California Cryobank, and Darryl Rawlings, the founder and chief
$1,000?According to Gallant, the veterinarians from its newly acquired business have treated hundreds of cats and dogs already with their
Those treatments have helped dogs with illnesses including osteoarthritis, atopic dermatitis, torn ligaments and chronic dry eye
Each treatment has been demonstrated to be effective in early clinical trials, and stem cell therapy is on the cutting edge of new
customers.During the procedure, vets deposit tissue from the operation in a special container that Gallant will collect and use to harvest
Black, chief scientific officer at Gallant, in a statement
